Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 07, 2019

SELL
$38.66 - $51.82 $923,973 - $1.24 Million
-23,900 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$36.72 - $67.73 $877,608 - $1.62 Million
23,900 New
23,900 $962,000
Q1 2018

May 10, 2018

SELL
$52.16 - $66.86 $1.26 Million - $1.62 Million
-24,200 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$49.6 - $60.87 $1.2 Million - $1.47 Million
24,200
24,200 $1.29 Million

Others Institutions Holding EGRX

About EAGLE PHARMACEUTICALS, INC.


  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.